LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Eric Linsley will participate on a panel titled "Leadership through Changing Times" at the Council for Entrepreneurial Development's Venture 2009 Conference in Pinehurst, NC
News | 04. 22. 2009
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.